Intravacc B.V.

Feb 23, 2021

Intravacc announces formation of Scientific Advisory Board

Feb 19, 2021

Dutch Intravacc starts concept design for multifunctional, high-capacity vaccine plant for national requirement

Jan 19, 2021

Intravacc announces completion of formulation and manufacturing process development of PRV-101 vaccine candidate for Provention Bio

Jan 06, 2021

Cristal Therapeutics and Intravacc Announce Strategic Collaboration to Advance Novel Vaccine Platforms

Dec 22, 2020

Dutch Vaccine developer Intravacc becomes public shareholding company effective January 1, 2021

Nov 16, 2020

Intravacc publishes positive phase I Shigella conjugate vaccine data

Nov 05, 2020

Intravacc appoints Prof. Dr. Virgil Schijns as Chief Scientific Officer

Sep 08, 2020

Intravacc Receives US NIH/NIAID Contract to Develop Enterovirus D68 Vaccine

Aug 25, 2020

Intravacc and Therapyx jointly develop the world's first prophylactic gonorrhea vaccine

Jul 29, 2020

Intravacc and Celonic to Develop and Produce a Novel COVID-19 Vaccine

Jun 22, 2020

Intranasal immunization With Intravacc's Experimental Whooping Cough Vaccine Confers Broad Protection

Jun 08, 2020

Intravacc and Versatope Sign Research Service Agreement to Develop Universal Influenza Vaccine Based on OMV technology

Jun 04, 2020

Intravacc Partners With Wageningen Bioveterinary Research and Utrecht University to Develop an Intranasal COVID-19 Vaccine